{"nctId":"NCT01120405","briefTitle":"Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery","startDateStruct":{"date":"2010-05"},"conditions":["Elevated Cardiac Risk","Coronary Arteries Disease Risk"],"count":600,"armGroups":[{"label":"Xenon","type":"EXPERIMENTAL","interventionNames":["Drug: Xenon"]},{"label":"sevoflurane","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sevoflurane"]}],"interventions":[{"name":"Xenon","otherNames":["LENOXe"]},{"name":"Sevoflurane","otherNames":["Sevo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥ 18 years\n* Scheduled for atherosclerotic vascular elective surgery with presumed fast-track,\n* Cardiac ischaemic risk supported by:\n\n  * History of myocardial infarction older than 1 month and/or\n  * Documented Stable angina (asymptomatic ± medical treatment) and/or\n  * History of coronary revascularisation, and/or\n  * Surgical Risk Index (\"Lee\" index) ≥ 3.\n  * Written informed consent\n\nExclusion Criteria:\n\n* Unstable angina within the last 30 days,\n* Non controlled arterial Hypertension .\n* Severe Cardiac heart Failure (NYHA IV)\n* Severe Chronic Obstructive Pulmonary Disease\n* Patient already randomized in another ongoing clinical trial\n* Patient with recent myocardial infarction (M.I) (less than one month )\n* Patient already included in a clinical trial\n* History of hypersensitivity to study drugs( i.e Xenon, propofol, sevoflurane, desflurane, isoflurane)\n* Malignant hyperthermia\n* Documented Elevated intracranial pressure\n* Preeclampsia or eclampsia\n* Pregnancy and lactation\n* Presumed uncooperativeness or legal incapacity","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Myocardial Necrosis (MN)","description":"Myocardial Necrosis: at least 1 value of serum cardiac troponin I above the 99th percentile (measurement performed by a central laboratory using the ABBOTT-ARCHITECT technique)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Cardiac Troponin I or T Above the 99th Percentile (Local Laboratories)","description":"At least 1 value of serum cardiac troponin I or T above the 99th percentile (measurements performed by local laboratories using different techniques)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Myocardial Infarction (MI)","description":"Patients with Confirmed Myocardial Infarction (MI) by the Investigators","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Cerebro-Vascular Event","description":"Patients with Cerebro-Vascular Event in the FAS","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Life-Threatening Arrhythmia","description":"Patients with Life-Threatening Arrhythmia in the FAS","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died From Cardiac Origin","description":"No patient died from a cardiac cause during the 3 postoperative days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Composite Endpoint","description":"Patients with at least 1 event among MN assessed by central laboratory, MI, Cerebro-Vascular event, Life-Threatening Arrhythmia and Death from Cardiac Origin","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null},{"groupId":"OG001","value":"56","spread":null}]}]}]},{"type":"SECONDARY","title":"Systolic Blood Pressure (SBP)","description":"Repeated Systolic Blood Pressure measurements during the perioperative period","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"146.1","spread":"21.6"},{"groupId":"OG001","value":"147.3","spread":"23.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90.6","spread":"21.3"},{"groupId":"OG001","value":"90.3","spread":"20.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"94.8","spread":"17.8"},{"groupId":"OG001","value":"83.8","spread":"14.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.8","spread":"25.1"},{"groupId":"OG001","value":"117.6","spread":"23.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156.0","spread":"26.9"},{"groupId":"OG001","value":"153.6","spread":"29.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"157.8","spread":"28.0"},{"groupId":"OG001","value":"144.6","spread":"26.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156.6","spread":"29.1"},{"groupId":"OG001","value":"153.4","spread":"27.6"}]}]}]},{"type":"SECONDARY","title":"Vital Signs (SBP and DBP Changes)","description":"Changes from baseline for Systolic and Diastolic Blood Pressure (SBP and DBP)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.2","spread":"25.4"},{"groupId":"OG001","value":"-14.2","spread":"26.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.8","spread":"26.6"},{"groupId":"OG001","value":"-10.7","spread":"25.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.9","spread":"24.7"},{"groupId":"OG001","value":"-12.2","spread":"25.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.05","spread":"14.91"},{"groupId":"OG001","value":"-6.15","spread":"15.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.32","spread":"14.53"},{"groupId":"OG001","value":"-1.46","spread":"13.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.73","spread":"14.05"},{"groupId":"OG001","value":"-2.61","spread":"13.90"}]}]}]},{"type":"SECONDARY","title":"Vital Signs (Heart Rate Changes)","description":"Changes from baseline for Heart Rate (HR)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.35","spread":"12.03"},{"groupId":"OG001","value":"6.35","spread":"12.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.81","spread":"13.64"},{"groupId":"OG001","value":"9.85","spread":"12.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.44","spread":"11.72"},{"groupId":"OG001","value":"8.90","spread":"14.14"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Chest Pain During the 3 Postoperative Days","description":"Patients with Chest Pain reported at least once per day during the 3 Postoperative Days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Urine Output","description":"Urine volume in milliliter (mL) during the first postoperative hours","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1279.0","spread":"723.1"},{"groupId":"OG001","value":"1324.4","spread":"631.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":17,"n":292},"commonTop":["Procedural Pain","Procedural Hypertension","Hypertension","Procedural Nausea","Hyperthermia"]}}}